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INTRODUCTION
Since very early times the naturally 
occurring derivatives of salicylic acid, notably 
methyl salicylate and salicin, found in the bark, 
leaves and fruit of a number of trees, such as the 
willow, have been used as remedies against many 
diseases. Various authors, e.g. Pliny, during the 
Classical Period recommended extracts now known to; 
contain salicylic acid as common factor in the 
treatment of a number of ills, though not all of 
these recommendations are in line with, current 
medical thought.
However, it was with the discovery in 
1874 by Kolbe1 of a process by which salicylic 
acid could be synthesised on a technical scale that 
it became the first organic compound occurring in 
nature to be manufactured as a commercial article. 
This also resulted in the much wider availability 
of the pure compound for medical use.
During the second half of the nineteenth 
century the effect of salicylic acid, either as the 
acid or in the form of one of its salts, on a wide 
variety of diseases was investigated. Probably the 
most important result of this was the simultaneous
2 \ finding by Strieker and MacLaganJ that salicylat©
was not only an antipyretic but was a specific
remedy for rheumatic fever.
Acetylsaiicylic acid was first 
introduced into medical practice by Wohlgemut4' and 
by Dreser*' in 1899 as a form of salicylic acid, 
more readily tolerated by the patient. Although 
this derivative was intended for the treatment of 
Rheumatic fever, the marked analgesic properties 
of this particular salicylate were soon noted, and 
its greatest use arose in that connection.
Modern research and clinical experience
hsem confirmed the value of several of the
therapeutic uses discovered earlier for salicylate,
such as its analgesic, antipyretic and anti-rheumatic 
c.
properties . Many other biological actions of 
salicylate have been reported, including its action 
as a "metabolic stimulant" by increasing the rates 
of oxygen consumption in animals and its ability to 
control mild hyperglycaemia and glycosuria in 
diabetes mellitus. (Hyperglycaemia and glycosuria 
are the respective states in which the blood 
glucose concentration is abnormally elevated and 
glucose is present in the urine).
It is generally agreed that the analgesic7 
8 Q
and antipyretic actions of salicylate are produced 
ty a central action of the drug on the brain. However, 
in the case of rheumatic fever, its mode of action 
is unknown. In the earlier part of the century 
it was believed- to act through the Central Nervous 
System, but in view of the number of pharmacological 
properties of salicylate occurring at cellular level, 
this is perhaps now less certain.
As mentioned before, at a relatively 
early stage in its therapeutic use salicylate was 
found to be of value in the treatment of rheumatic 
fever. Although early reports on its use cast 
some doubt on its real benefits in this disease, this 
was probably because the dosage in common use up ta 
the second decade of this century was considerably 
less than the 10 to 12 g. salicylate per day considered 
necessary at the present time. Today, salicylic acid 
in the form of its sodium salt or as the acetyl 
derivative is recognised as one of the best remedies 
for rheumatic diseases10. Stockman11 observed that 
the m- and £- isomers of salicylic acid did not share 
the beneficial action of the o-isomer, and it has
been found that the sodium salts of the o-cresotic
12
acid (3-methylsalicylic acid) » ^-resorcylic
-3-
acid (2,6-dihydroxybenzoic acid)11, and gentisic
acid. (2,5-dihydroxybenzoic acid)14 are as effective
as sodium salicylate in this disease. It would:
appear that the therapeutic action of these compounds
is a property of the salicylic acid grouping.
During the latter part of the last
century there were numerous clinical reports that
the drug inhibited diabetic glycosuria . That
salicylate is therapeutically active in diabetes
mellitus has been established clearly in animals by
Ingle1**, and confirmed by Smith, Meade and Bomstein1 .^
17In the diabetic patient it has been shown to reduce
blood sugar and glycosuria, and to control moderately
severe ketosis (i.e. the presence of ketone bodies in
idthe urine). Reid and Lightbody showed that it
was possible to replace a proportion of the insulin
required by diabetic patients by salicylate.
It is of interest to note that £-cresotic
19acid has a similar hypoglycaemic action .
The effect of sodium salicylate in 
increasing the rate of oxygen consumption of
on pi 22 23
experimental animals ’ and man ’ is now well 
established. It would appear that this phenomenon 
occurs only in those benzoic acids possessing the
-4-
salicylate grouping. Thus Meade24- found that only-
salicylic acid among all the mono— and di—hydroxybenzoic
acids increased the rate of oxygen consumption of
rats. Hall, Tomich and Woollett2  ^investigated a
number of compounds chemically related to salicylic
acid. Only salicylic and acetylsalicylic acid were
found, to increase the rate of oxygen consumption of
rats or mice; 2,5- and 2,6-dihydroxybenzoic acid,
m- and £-hydroxybenzoic acid, and salicylamide were
found to be inactive. The effect of eighteen
substituted benzbie acids on rats was examined by 
26Andrews . Of the compounds studied at the doses 
used, only salicylic acid and o-, m-, and £-cresotic 
acid were active, the molar potency ratios of each 
of the three cresotic acids as metabolic stimulants 
relative tbo salicylic acid being 2.61, 1.78, and 
1.89 respectively. All the mono-hydroxysalicylic 
acids, salicyluric acid, and 5-aminosalicylic acid 
were either inactive or were metabolic depressants.
acid
6-Kethylsalieylic^, at the low dose used, owing to 
its toxicity, was inactive. These results indicated 
that the introduction of a methyl group into the 
benzene ring at positions other than the 6-position 
increased the potency of salicylic acid as a metabolic
-5-
stimulant, the greatest increase being with the
methyl group in the ortho position to the phenolic OH.
With a methyl group in the 6-position the toxicity
of the compound was greatly increased, possibly
through steric inhibition of detoxication reactions
such as the conjugation of the carboxyl group with
glycine. Measurements of the metabolic stimulant
action of 6-methylsalicylic acid could not therefore
be made with doses as high as with the other acids.
It is also of interest that some preliminary
measurements with 3-phenyl salicylic acid made by 
26Andrews suggested that it was even more potent 
than £-cresotic acid. The results in this paper 
also, established that the differences in potencies 
of the different cresotic acids relative to 
salicylate did not depend on the rates of degradation 
or excretion of the drug.
All the above papers have described 
experiments on the whole animal. However, a number 
of in vitro studies have shown that salicylate 
stimulates oxygen uptake at cellular level,
Fishgold, Field and Hall27 observed an increase in 
the rate of oxygen consumption of rat brain slices 
at concentrations of 0,06 to 0,56 mM, followed by a
- 6 -
progressive fall at higher concentrations. No 
stimulation of respiration was noted with thick 
liver slices at any concentration of sodium
p O
salicylate. Sproull investigated the effect of 
sodium salicylate on the rate of oxygen consumption 
of mouse liver slices. He established reproducible 
dose-response curves in the presence of concentrations 
of salicylate in the range 3*5 x 10~^M to 7.5 x 10~^M; 
from, concentrations of 3*5 x 10“^  to: 2 x 10"^M there 
was a progressive increase in the rate of oxygen 
consumption, followed by a fall at higher concentrations.
From this brief survey of previous work
it would appear that only those benzoic acids having
hydroxyl groups in the ortho position to the carboxyl
group possess anti-rheumatic, anti-diabetic, or
metabolic stimulant properties. However, it should
be noted that the presence of this salicylate grouping
in a molecule does not necessarily cause the molecule
to possess all three or even any one of the above
properties, since other groups in the benzene nucleus
may counter its activity in any of these respects.
Thus /-resorcylic acid which, is reported to possess
13anti-rheumatic characteristics , has no action as a 
metabolic stimulant.
-7-
At this point one might mention
2,4-dinitrophenol, a compound with a number of
structural similarities to the salicylate ion, such as
the phenolic hydrogen hydrogen-bonded to an oxygen
atom, of an electron withdrawing group. This
compound has a surprising number of pharmacological
properties specific to that structure and similar to
those of salicylic acid. It is a metabolic stimulant2^’
this property being found in the case of nitrophenols
only in compounds possessing the 2,4-dinitrophenol 
^1grouping , and is also found to have a qualitatively
2^similar anti-diabetic action to salicylate*^ *
However, it was found inferior to aspirin in this 
last respect, though a more potent metabolic stimulant.
To summarise the preceding paragraphs, 
it can be said that the biological activity of 
salicylate respecting its anti-rheumatic, anti-diabetic, 
and metabolic stimulant properties would appear to be 
a function of the 2-hydroxybenzoic acid grouping.
The position is, of course, complicated by the 
presence of further substituents, loss or enhancement 
of activity occurring in some respects but not in 
others. It was also mentioned that 2,4-dinitrophenol 
shows similar activity to salicylate in its anti-diabetic
- 8 -
and metabolic stimulant properties at least. In 
this case the biological activity is inherent in 
the 2,4-dinitrophenol grouping.
Physico-chemical aspects
To explain these biological properties, 
perhaps the first step is to compare salicylic acid 
with its isomers m- and £-hydroxybenzoic acid, the 
first being biologically active in the respects 
previously considered, and the latter two inactive.
One notable difference is the much stronger acidity 
of salicylic acid (see Table 1). This has been 
attributed^ to hydrogen bonding between the 
phenolic hydrogen and the carboxylate anion, resulting 
in stabilisation of the molecule as the salicylate 
ion. As a concomitant of this, the phenolic pKa is 
higher in the salicylate ion than with the other two 
isomers, and this for the same reason. Intramolecular 
hydrogen bonding is not, of course, possible between 
the phenolic hydrogen and the carboxylate group in 
the m- and jd- isomers for sterie reasons.
The structural and resulting 
physico-chemical properties of salicylic acid are 
sufficiently unusual to warrant further investigation 
of the physical properties of its chelate bond in 
an attempt to correlate physical with the biological 
properties of the molecule.
-10-
TABLE 1 .
The carboxylic dissociation constants 
of the monohydro3^r benzoic acids
105. Ka
£-hydroxybenzoic acid 101
m-hy dr oxybe nzo ic acid 8**27
£-hydroxybenzoie acid 2*95>
-11-
It has been suggested that compounds 
possessing both chelating groups and biological 
activity may possess this latter function through 
their ability to complex with metal ions. A few 
examples may be instanced. The action of compounds 
analogous to 8-hydroxyguinoline in inducing diabetes 
mellitus in rabbits parallels their chelating tendencies, 
and the idea was put forward that their diabetogenic 
action might be associated with their ability to 
react with trace metal ions^. Some evidence has 
recently been obtained that the antibiotic terramycin 
inhibits the alanine dehydrogenase of Mycobacterium 
Tuberculosis through the formation of a chelate compound 
with the magnesium ion, this being the actual inhibitor^?. 
The antibiotic tetracycline, of which terramycin is 
an alcoholic derivative, has been shown to be bound to 
deoxyribonucleic acid and to serum albumin in the 
form of a macromoleeule-metal ion-tetracycline complex.^ 
This result would strengthen the view that the 
tetracyclines may exert some of their biological effects 
by complexing with macromoleoules through metal ions.
It is well established^ *40 that the total 
concentration of salicylate in human blood plasma 
is much greater than the concentration of free 
salicylate. Using dialysis and ultrafiltration
-12-
techniques it was found39 that at a concentration of 
4 mg per 100 ml 90^ > of the tatal salicylate was 
hound to protein constituents;at a concentration of 
70 mg per 100 ml, the figure was 54?&. This phenomenon 
of the binding of organic molecules by proteins may 
arise through physical forces such as electrostatic 
interactions or hydrogen bonding^, but it has been 
shown that it ean occur through the mediation of a 
metal ion between the protein and the small molecule^. 
In the case of a molecule such as salicylic acid with 
its Inown metal complexing properties it is possible 
that its binding to proteins is by such a chemical 
mechanism.
It is very probable that a number of the 
biological actions of salicylate may arise as a result 
of its tendency to associate with plasma protein.
In 1959 Christensen^ noted that using thyroxine 
labelled with -^3^1 and bound to protein within a 
dialysis apparatus, there was a substantial increase 
in the amount of passing through the membrane
on adding salicylate or 2,4-dinitrophenol to the 
protein compartment. This he interpreted as being due 
to an increase in free thyroxine. It would appear 
that the salicylate or 2,4-dinitrophenol displaced
-13-
the thyroxine hound to the protein. A later paper^ 
noted that with plasma salicylate concentrations of 
30 mg per 100 ml or higher there was an increased 
activity of plasma enzymes. This phenomenon could 
readily he explained if it were assumed that salicylate 
was more strongly hound to protein at the enzyme 
binding sites than the enzyme itself. The release 
of thyroxine by a mechanism such as this might explain 
the increase in metabolic rate resulting in mammals 
treated with salicylate, this being one of the hormonal 
actions of thyroxine.
A mechanism of this nature would explain 
the wide range of the biological actions of salicylate 
on whole animals. Furthermore, if the binding sites 
of these biologically active materials are metal ions 
already eomplexed to the plasma proteins, a ready 
explanation of their displacement by salicylate would 
be at hand.
However, this is all surmise, and the true
picture may be very different. But, whatever, the
mechanism of action of salicylate may be, it would be
might
expected that it should, be possible in a group of 
substituted derivatives to correlate the complexing 
tendency of the molecule with metal ions with its
-14-
biological action, the stability of the complex being 
indication of the total effect of the 
various factors of molecular structure and environment 
which would affect its biological action. For that 
reason the subject of this work was an investigation 
into the complex formation of some derivatives of 
salicylic acid with ferric ion. In view of the 
similarity in biological action between salicylic 
acid and 2,4-dinitrophenol in many respects, this 
compound was also included for comparison. The 
compounds studied either had been or were about to 
be investigated with regard to their biological activity.
-15-
General Methods
The substances studied can conveniently 
be divided into three groups: firstly, salicylic 
acids substituted in the 3“P°si'fcion with alkyl or 
aryl groups; secondly, the hydroxy-salicylic acids; 
and thirdly, the remaining acids. The first group 
contained £-cresotic acid, 5-iso-propylsalioylic 
acid, 3-tert-butylsalicylic acid, and 3“Pke*iylsalieylic 
acid. The second comprised Y~ and^-resorcylic acid 
(2,6- and 2,4-dihydroxybenzoic acid respectively), 
and would have included gentisic acid (2,5-dihydroxy- 
benzoic acid), a minor detoxication product of salicylic 
acid, but for its ready oxidation by ferric ions.
The remaining acids, namely m- and £-cresotic acid 
(4- and 5-methylsalicylic acid respectively), 
6-methylsalicylic acid, salicyluric acid (the principal 
detoxication product of salicylic acid), and 2,4- 
dinitrophenol made up the third group. The structural 
formulae of the compounds whose complex formation 
with iron(III) was studied are shown in Figure 1.
The choice of metal ion in this 
investigation was somewhat arbitrary, and partly 
arose from the known ability of the ferric ion to 
form stable complexes with phenols in general and
-16-
C O O H
salicylic acid 
C O O H
C O O H
o_-cresotic acid 
C O O H
OH CH OH
CH
jD-cresotic acid 6-methylsalicylic 
acid
C O O H
m-oresotio acid
C O O H
c K c h ^
3-i^o-propyl- 
salicylic acid
COOH
ho^ X ^ oh
X J
y-resorcylic
acid
C O O H
^-resorcylic
acid
OH
CO.NH.CH2.COOH 
OH
salicyluric
acid
2,4-dinitrophenol
Fig. 1. The structural formulae of the acids studied.
-17-
salicylates in particular, and also from the known 
importance of iron in metaholism.
Ihe well-known colour reaction of 
salicylates with ferric ions was reported as early 
as 1798 hy White^ in connection with studies of
extracts from willow bark. It was suggested by
46 <-»Vogel in the 1870's that the reaction might be 
used in the detection of iron, and since then it
has become a standard method for the determination
4-7 48 49of iron and of salicylic acid . Ihis
colour reaction results from the association of the
ferric ion and the salicylate molecule. In a,
neutral solution of salicylic acid the carboxylic
group is completely ionised. On adding a solution
of ferric ions to it there is a very considerable
liberation of hydrogen ion which can be explained
on the assumption that the phenolic hydrogen is
released as an ion. In the event of a 1 • 1
51complex: being formed this would indicate a structure 
such ass
-18-
At this date there are a very
considerable number of methods available for the
quantitative investigation of complex formation.
o
Of these methods, potentiometry, polaa^graphy,
spectroscopy, solubility and ion exchange
have all been used in experiments involving iron(lll)
50complexes . Although other methods have their 
uses, by- far the most accurate and widely applicable 
technique currently available is that of 
potentiometry. In fact, this method, often in 
combination with spectrophotometry, has been used 
by most of those investigating the iron(lll)- 
salicylate system. This is due, perhaps, to the 
most notable properties associated with the complex^ 
via,, the marked colour of the complex, the drop in 
pH on its formation, and the reduction in the free 
iron(III) concentration in solution caused by the 
complexing.
A number of authors have examined the 
iron(IIl)-salicylic acid complexes using a
51-58combination of pH measurements and spectrophotometry 
Only two papers-^’ appear to have been published 
using combined pH and oxidation-reduction potential 
measurement to investigate the system. However, the
-19-
consensus of opinion of all these papers is that 
iron(III) forms three complexes with salicylic 
acid, of formula FeR , FeR~ and ReR^“, where R 
represents "O.GgH^.COO”. The complex: FeR+ is of 
a violet colour and is formed in strongly acid 
solution. On raising the pH the species FeR2~ and 
FeR^~ make their appearance in turn, the first of 
these "being red and the second yellow.
Of the other salicylic acidL derivatives, 
only o-cresotic acid, m-cresotic acid and yS -resoreylic 
acid, have heen investigated previously as regards 
their complex formation with iron(III) in aqueous 
solution. Tripathi and Prakash , using a 
spectrophotometrie technique, found that o-cresotic 
acid formed a 1:1 complex with iron(III) ions.
58The complexes of ferric ion with m-cresotic aeid^
cQ fi"l « _ f i
and with jS -resoreylic acid5 ’ “ 5 were found to
he similar in type to those of salicylic acid, and 
it has heen suggested^^ that the 1:1 complex of the 
latter acid he used for the determination of ferric 
iron.
As regards the experimental technique 
used in this work, it was decided to adopt the 
procedure of simultaneous pH and oxidation-reduction
-20-
potential measurement in the system, since this was 
the most versatile method and at least as accurate 
as any other. The elegant graphical method of 
analysis of results used by Igren^4 was followed, 
as was his use of sodium perchlorate as "swamping” 
electrolyte. Using this experimental method a 
number of assumptions are made, and these will be 
considered in turn.
Initially it was hoped to use 3 M sodium 
perchlorate as swamping electrolyte to overcome 
activity factor and liquid Junction difficulties , 
and because values for the iron(III) hydrolysis 
constants were obtained in that medium by Hedstrdm.
67 68(It has been reported ' * that the perchlorate ion 
has a weak complex forming tendency, but in the presence 
of a large and- constant excess of perchlorate ion 
this need not be taken into account in the calculation 
of the equilibria). However, as will appear later, 
in most of the experiments the concentration was 
0.1 M.
The equilibrium solutions studied contained 
both ferric and ferrous ions, each kept at a fixed, 
total concentration in each experiment. Since the 
concentration of free ferric ions was obtained from 
the oxidation-reduction potential of the system not
in absolute terms but relative to the ferrous ion 
concentration, it was important that this should 
remain constant and not be decreased by complexing 
with either organic acid or hydroxyl ions. From 
HedstrBm's work on its hydrolysis^9 the degree of 
hydrolysis of ferrous ion is negligible below pH 6.5 
and is still less than 1 at pH 7*5* Thus the influence 
of this on the determination of the stabilities of 
the 1:1 and 1:2 complexes, predominant in the acid 
range of pH, will be negligible. As regards complexing 
of the ferrous ion by the chelating agent, lgren^3 
investigated the possibility in the ease of salicylic 
acid by varying the ratio: of the concentrations of 
ferric to ferrous ion in the system. The values of 
the constants obtained were not dependent on the 
ratio of ferrous to ferric iron. From this result 
it was concluded that the complexing of ferrous ions 
by salicylate under the conditions of the experiments 
was negligible. This was repeated to a lesser extent 
in this series of experiments in that each compound 
was investigated using solutions containing different 
ratios of the two forms of iron ion.
Certain practical difficulties arose in 
using the 3 ^ perchlorate medium, so that for most of 
the measurements a medium brought to an ionic strength
of 0.10 was used. One difference resulting from
this was that while the complexing of ferric ions
- 22 -
by perchlorate would now be negligible, it would 
no longer be correct to assume that the activity 
factors, particularly those of polyvalent ions, 
would be constant. It was, however, assumed that, 
within experimental error, they were constant over 
the concentration range studied. Also, it was not 
possible to utilise a value for the liquid junction 
potential at the solution phase/salt bridge solution 
phase boundary.
Even at the most acid pH!s used in this 
work, a significant proportion of the total ferric 
iron concentration in a solution of ferric 
perchlorate is present as hydroxyl complexes. 
HedstrBm^ found that the species FeOH2* , Fe(OH)* , 
and Fe2(0K)2^+ are formed, and derived values for 
their formation constants at 25° and in 3 M 
perchlorate medium, These values were used in 
the analysis of the results from the work in 3 M 
perchlorate. A later paper by Milbura and Vosburgh7° 
confirmed Iledstr8m!s work, and these authors obtained 
equations relating the formation constants of the 
species FeOH24* and Fe2(OH)2^+ to ionic strength, 
from which it was possible to calculate their values 
at an ionic strength of 0.1. Aa estimate of the 
value of the formation constant of the species
Fe(0H )2 at ionic strength 0.1 was made using the 
figures from the papers of HedstrSm and of Milhurn 
and Vosburgh.
Fortunately, the complexing power of 
all the compounds containing the salicylic acid 
grouping was sufficiently great for the actual 
free ferric ion concentration to be very small 
over most of any one titration. Hence the proportion 
of the total ferric ion present as hydroxyl complexes 
was very small, and any possible error in the calculated 
correction for these hydroxyl complexes would be 
negligible in the final result.
As stated before, the method of Igren 
was used in analysing the experimental results.
This^ is given below.
-24-
Consider the theory of the method 
applied to salicylic acid, represented hy RH^.
The method involved the simultaneous measurement of 
pH and oxidation-reduction potential in a solution 
containing sodium salicylate, ferric and ferrous 
perchlorate, sodium hydroxide, perchloric acid 
and sodium perchlorate. Hence the electromotive 
force of the following cells was measured:
1. - Ag AgCl(s) HC1 glass solution reference
electrode
2 . - Pt solution reference electrode +
(The reference electrode was a silver/silver 
chloride electrode in the 3 M perchlorate work, 
and a calomel electrode for measurements in ionic 
strength 0.1.)
The equilibrium constants for the 
formation of the FeR , FeRg , and FeR^ complexes 
are defined by:
Fe^+ + RH" H+ 4- PeR+; *1 a
H  *l>]
Fe3 + 2EH ^  2H + FeR“; Kg _ h2.JjeEj
[®]2- M
Fe3+ + 3BH" 3H+ + FeR^'; £3 _ h3. [peR^
[RH] 3.[Pe]
or in a more general form;
Pe3 + + nRH" nH+’ +• PeRn(3_2n) Kn _ h.n.[peRj
W  M
where h is the hydrogen ion concentration and all 
concentrations are expressed, in mM. The signs for 
electrical charges in the equilibria are omitted 
for convenience.
The E.M.P. of the first cell above is
given by
B - - 59.16 log h - E.
G rl e ’ £ L  3
where E is a const sent (in mV) and E . the liquid 
0 ’ 01 J
junction potential
The E.M.E. of the second, cell is obtained
from
_  - 59.16 log [Pe3+] / [>e2+] - B j
0 ,rt i ft
where E is a constant.
°’pt inf,*"
-26-
*“ “ • * ■ * * * & / >  ■ H i  * 59.W 1 «
LFe2^  (h + 1)
where h =M  t - LFe3f| and [Fel ig the total 
|>e3+]
concentration of iron (III).
If the total concentrations of iron (III) 
and iron (II) are each constant during an experiment, 
this equation can he written
E - + 59.16 log (b + 1)
where
E - E _  - 59.16 log rFe] . /Tve2^
0 ’Pt/^62
Since the total concentration of iron (III) 
is the sum of the concentrations of iron (III) present 
in the different species containing it, and similarly 
with the total concentration of salicylate, the 
following equations are valid:
[?elt = jjFe] + [FeOH] + [Fe(OH)2] + 2[Fe2(0H)J
+ [FeR] + [FeRg] +  [jFeR^ ] (2)
[R] t  “ '[EH]'t‘ +  [FeH] +  2 [i'eE2] +  3M  (3)
where is the stoichiometric concentration of
t
salicylate.
By a consideration of the reactions 
producing or consuming hydrogen ion, the following
relation is derived:
- 27-
*■ m CH]t~ [0H]t +‘ LFeE] + 2 tFeE2] ^ 3[FeRJ] - [rh2]
-f- [peOH^I +  aJpetOHjg] +  pjregfOH)^
The hydroxyl complexes present are 
FeOH2+, Fe(OH)2 and Fe2(OH)24+.
The general expression for their 
equilibrium constants is
^nnt =  31 * 0^en ^ H ^m3
[Pe]n
By combining equations (1) and (5) with (2):
M *  =  M  + + v W  4- 2k2 2 - W 2
h h2 h2
+ Kr M M , + K3.[HH]3[Fe]
h h2 h3
i.e. £l?el - [jPeJ b k12 2k22[W] K^RH^
—   -E-+ ^ - + ^ —  + —
(5)
+  k 2 M 2 + K3M 3
hfc h3
i.e. h =  k ’ + KjCffil +  E2M 2 +  K3M 3
h h2 h3 'b)
where k*, the small correction term for the hydroxyl
complexes, is equal to ( kll k-^ 23£22Di'e3(
r r  ■ ?  T 5 - !
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If the last term of equation (6) is 
assumed to he small compared with, the other terms, 
and this should he so at lower pH's, the following 
equation is obtained: -
(b - k ) rjltn ~ ^1 +* ^2
m  ' ^  (7)
The value of the term on the left hand 
side of the equation can be calculated from 
experimental data. If this is plotted against 
the function |j*H|/h a straight line should be 
obtained, the intercept being and the slopeK^.
To calculate £rh] the dissociation 
constant of the salicylic acid must be known:
K = Dafl h
(8)
By subtracting equation (4) from (3):
[E]t - h - [EH] +  2[BH2] - [H]t + [0H]t
- [FeOH] - 2[Fe(0H)2] - 2[Fe2(0H)2])
and combining this withi (8):
[eh] (1 + |fe ) - [a]t +  [H]t - [0H]t - k +  [FeOH] 
a _
+ 2[pe(OH)23 + 2[Fe2(0H)2J ^
from this equation be calculated.
At higher pH's where it is no longer 
correct to assume that the last term in equation (6)
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is negligible compared m t h  the others, the value 
of can be obtained from the rearranged form of 
equation (6):
p  - k,)[is] ■ Ei}[iq " K2 + k 3 ^
Assuming has been determined at a 
lower pH range, on plotting the left hand side 
of equation (10) against [eh]/h, a straight line 
should be obtained with intercept Kg 811(1 gradient
The experimental details of the method 
are now given in the following section*
(1 0 )
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EXPERIMENTAL
Apparatus
The apparatus used in the E.M.P. 
measurements consisted of a titration cell, a 
liquid junction assembly, and a reference electrode, 
all maintained at 25° ± 0.01° in an oil bath fitted 
with a toluene-mercury thermo-regulator.
The titration cell was made from a four­
necked flask (see Pig. 2). Three of the necks held 
the two platinum electrodes and the nitrogen inlet.
The fourth, and largest neck, was used to hold one 
limb of the liquid junction assembly, the glass 
electrode, and the tips of the two burettes.
The design of the liquid junction assembly 
and reference electrode depended on whether 
measurements were being made in 3M perchlorate or in a 
medium of ionic strength 0*1. In the 3M perchlorate 
measurements the apparatus was similar to that used 
by Sgren^ and was of form:
AgCl lOOmM NaGI 
3000mM NaC104
NaClO^ 3M
The liquid junction consisted of a glass tube drawn 
out to a fine capillary in the form of a J (Pig. 3a). 
The Ag/AgCl electrode was prepared by the method
Brown^ "**
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For the series of measurements at an 
ionic strength of 0.1 various modifications were 
made to the apparatus. With the liquid junction 
and reference electrode system shown above, a drift 
in liquid junction potential with time was noted.
Ihis was traced to the coarse nature of the J-shaped 
liquid junction, which, while being perfectly 
satisfactory with a solution containing 3M perchlorate 
did not function well with a solution containing 
perchlorate at a strength of 0.1M. It was replaced 
by a much finer, differently shaped junction (Fig. 3b) 
lo reduce the liquid junction potential, ammonium 
nitrate was used in the salt bridge on account of 
the approximately equal ionic mobilities of the 
ammonium and nitrate ions. However, a solution 
5M in ammonium nitrate gave drifting liquid junction 
potentials, whereas very steady potentials were 
obtained with a 1M solution, but it possessed too 
high a resistance. A 2.5M solution in the salt 
bridge was found to rwuult "fa s- steady potential 
and to possess a sufficiently low resistance for
practical use.
For the experiments described in the
last paragraph, the silver/silver chloride electrode
- 3 2 -
Fig. 2
Fig. 3
ode
salt bridgeburette tips
platinum , 
electrodes
nitrogen 
, inlet
The titration cell.
(a) (b)
Liquid junction shapes used (a) in 3^ and 
(b) in 0.1M experiments.
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in 0.1 M sodium chloride solution was replaced by a 
saturated calomel electrode, and the final electrode 
assembly used is shown in Fig. 4.
During titrations nitrogen was passed 
through the reaction mixture. The nitrogen used 
was the "White Spot" variety supplied by the British 
Oxygen Company. It was freed from any oxygen and/or 
carbon dioxide present by passing it first through 
Fieser!s solution^ and then through a glass tube 
packed with copper, turnings at a temperature of 
450° Ihe activity of the copper in the tube
was regenerated by passing hydrogen over it on the 
completion of an experiment. Before entering the 
titration cell, the nitrogen was bubbled through a 
solution of sodium perchlorate, 3 M in the case of 
the experiments in 3 M perchlorate and 0.1 M in the 
experiments at ionic strength 0.1
In the measurement of the oxidation- 
reduction potentials, two bright platinum electrodes 
were used simultaneously. Before use these were 
cleaned with boiling nitric acid and rinsed with 
distilled water. Electrodes treated in this way 
were found to agree in potential to better than
0.1 mV.
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calomel
electrode
solid
potassium
chloride saturated potassium 
chloride solution
■ level of oil 
• in bath
2-5M ammonium nitrate 
solution
Fig. 4. The saturated calomel half cell and salt 
bridge used in the 0.1M experiments.
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The oxidation—reduction potentials were 
measured with a Croydon Precision Instruments Co. 
potentiometer coupled with a Pye ,,Scala^Ip, 
galvanometer, this system having a sensitivity 
of 0.1 mV.
The hydrogen ion concentration was
determined with a Cambridge pH meter, accurate to
to.01 pH unit. Various commercial glass electrodes
were used, in particular the Cambridge glass
electrode. The pH meter was standardised with 
-2 —310 and 10 M solutions of perchloric acid made 
up to the appropriate ionic strength with sodium 
perchlorate.
The method of standardisation of the
pH meter differed slightly between the 3 M
perchlorate experiments and the experiments at ionic
strength 0.1. In the former experiments the H.M.F.'s
—2 — 3of the cells containing 10 and 10 M perchloric 
acid ( [ciO^-] - 3 M) were measured and the
difference between them taken to be the gradient 
k)
•3^ 1-ug h)/dB. The value of this gradient and the 
value of E at h = 1 ni were substituted in the 
equation
E„, = E- _ m log h - E .
G1 OtG1 J’
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where ^0 ,oi is a constant (in mV) for Cell 1, m is 
the gradient cLE/d(log h), and E, the liquid junctiont)
potential. Under the conditions of the 3 M
experiments the value of E^  was approximately 
o 64- 6 5- O.Oloh mV * . Hence the values of h corresponding
to different values of E ^  were calculated from this.
In the experiments at ionic strength 
0,1, the gradient dE/d(log h) was the theoretical 
one, viz. 59*16 with E measured in mV, and the pH 
meter was therefore used directly for measuring pH,
"being standardised with a 1 mM solution of perchloric 
acid (ionic strength 0.1) and the performance of 
the glass electrode checked with a 0.1 mM solution 
of perchloric acid (ionic strength 0.1), which 
solutions were assumed to have hydrogen ion concentrations 
of 10-3 and 10"^ M respectively.
The glass electrode was, of course, 
then calibrated in terms of hydrogen ion concentration, 
not activity.
Chemicals
Constant boiling hydrochloric acid (A.R.) 
was used as the primary standard for acidimetrie 
and alkalimetric titrations. Standard sodium 
hydroxide solution was prepared by diluting a 16.5 M 
sodium Hydroxide (A.R.) solution with carbon dioxide-free
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water and standardised against diluted- constant 
boiling hydrochloric acid aij the boiling point using 
phenol red indicator. This method was used in all 
mineral acid - sodium hydroxide solution titrations.
A solution of iron(lll) perchlorate was 
prepared by dissolving ferric chloride (A.R.) in 
water and precipitating ferric hydroxide from it 
with aqueous ammonia (A.R.) . The ferric hydroxide 
was separated from adsorbed salts by dialysing it 
for several days in running (Glasgow) tap water. 
Finally it was filtered and washed with distilled 
water. No precipitate was then obtained from the 
washings on adding silver nitrate solution acidified 
with dilute nitric acid to .them. To the pure ferric 
hydroxide so obtained was added an equivalent amount 
of 60$ perchloric acid (A.R.) and the mixture heated 
on a water bath under reflux for 11 hours. The 
resulting solution of ferric perchlorate and excess 
perchloric acid was separated from residual ferric 
hydroxide by filtration using a filter aid.
Iron(II) perchlorate solution was 
prepared by the addition to barium perchlorate 
solution (prepared from barium carbonate (A.R.) 
and A.R. perchloric acid) of an equivalent amount
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of ferrous sulphate (A.R.) solution. The solution 
obtained by filtration gave negative tests for 
sulphate with barium chloride and for barium with 
dilute sulphuric acid.
Stock solutions containing ferric and 
ferrous perchlorate in different concentration 
ratios were prepared from the above solutions.
The perchlorate ion concentration was determined by 
an ion exchange method. Total iron concentration 
was measured by reduction of a sample with stannous 
chloride and titration against standard potassium 
dichrornate solution. The ferrous ion concentration 
was found by direct titration with potassium 
dichromate solution. The ferric ion concentration 
was determined by difference ((Pe) ^-0^a2. ~ 
the hydrogen ion concentration also by difference.
( [C104-] - 3 [ > 3+] - 2 [Fe2 +] )
An approximately 8 M solution of sodium 
perchlorate was prepared from 60$ perchloric acid 
(A.R.) and A.R. sodium carbonate in deficit. After 
removing dissolved carbon dioxide by bubbling 
nitrogen through the solution, the pH of the solution 
was raised to 10 with 16 N sodium hydroxide and the 
solution left for 24 hours. It was then separated 
from precipitated impurities by filtration through
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acid washed filter aid. The filtrate was acidified
with perchloric acid and neutralised with carhon
dioxide-free sodium hydroxide solution. The
concentration of the final solution was determined
using an ion exchange technique.
Initially, the sodium perchlorate solution
was prepared from commercially available sodium
perchlorate. However, it was found that oxidation
of ferrous ion occurred in solutions made up with
this sodium perchlorate, probably as a result of the
presence of sodium chlorate as an impurity in the
sodium perchlorate.
Most of the organic acids were obtained
commercially. However, the samples of jo-cresotic
acid and of 6-methylsalicylic acid were supplied by
Dr. C.J.W. Brooks and those of 3-tert-butyl- and
3-isc-propyl-salieylic acid by Dr. 0. Fancher (Miles
Laboratories Inc.). The 2f-resorcylic and salicyluric
acid used were synthesised, the first by the
74carboxylation of resorcinol under pressure , and the
7 R
second following the method of Fischer . The final 
purities of all samples were checked by paper
chr omat ography.
All melting points are uncorrected for
the emergent stem of the thermometer.
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o-cresotic acid
This acid was purified by recrystallizing 
twice from benzene, then from methanol and water, and 
finally subliming twice at 80 to 100°C and 0.3 mm.
pressure. The final melting point of the sample
was 163-164°C (literature value^, 163-164°C).
salicylic acid
Salicylic acid (A.R.) was recrystallized 
from benzene and sublimed at 80-100°C and 0.2 mm. 
pressure. The melting point of the purified 
sample -was 157-159°C (literature value^, 159°C).
m-cresotic acid
m-cresotic acid was recrystallised twice 
from benzene, twice from methanol and waterr and 
finally was sublimed twice at 80-100°C and 0.3 nun.
pressure. The melting point of the purified
compound was 175—176°C (literature value 177°C).
p-cresotic acid
The sample of £-cresotic acid was purified 
by crystallisation using benzene as solvent, followed 
by two sublimations at 80-100°C and 0.3 pressure. 
The final melting point was 149—151 0 (literature 
value76, 153°0).
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6-methylsalicylic acid
A sample of crude acid was readily 
purified by subliming twice at 130°C and. 0.1 mm. 
pressure. The melting point of the purified sample 
was 170-171°C (literature value^, 170-171°C).
3-dso-propylsalicylic acid
A pure sample of 3-iso-propylsalicylic 
acid, was prepared by sublimation fromi the technical 
product at 120°C and 0.1 mm. The final melting 
point was 65-66°C.
-resorcylic acid
This acid was prepared, along with the yS-
74isomer, by the carboxylation of resorcinol . It. 
was separated from the yfi -resorcylic acid by 
fractional crystallisation from benzene, and was 
further purified by sublimation at 130°C and 0.1 mm. 
pressure. The purity of the final product was 
checked by paper chromatography using an iso-propyl 
alcohol-ammonia (0.880)-water (10:1:1 ) solvent.
(H^ . values; 1  acid: 0.70-0.75; f* acids 0.29-0.30). 
Its melting point was 164.5-165 C (literature v a l u e 76 
150-170°C).
—resorcylic acid
-resorcylic acid was purified by
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recrystallisation from water and by sublimation at 
160°C and 0.1 mm. pressure. Its melting point 
was 222-223°C (literature value^, 213°C).
3-phenylsalicylic acid
Technical grade acid was recrystailised 
several times from a benzene-acetone mixture, and 
then from benzene alone, resulting in the separation 
of 3-phenylsalicylia acid from a high melting 
dicarboxylic acid impurity, Finally it was 
sublimed at 130°C and 0.3 mm. pressure. The melting 
point of the pure compound was 186-187°C (literature 
value^, 180°C) •
3-tert-butylsalicylic acid
A sample of 3-tert-butylsalicylic acid 
was sublimed twice at 120°C and- 0.1 mm. pressure.
The melting point was then 156-158°C.
salicyluric acid
A sample of this acid was purified by 
recrystallisation from chloroform—methanol mixture, 
followed by sublimation at 130°C and 0.2 mm. The 
final melting point was 166-167°C (literature value^^ 
170-172°0)
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gentisic acid
G-entisic acid was dissolved in water 
and precipitated from solution "by the addition of 
concentrated hydrochloric acid. The precipitated 
crystals were recrystallized from chloroform-acetone 
mixture, and finally sublimed at 130°C and 0.1 mm. 
pressure. The melting point of the pure sample 
was 202-204°C (literature value^, 200°C).
2.4-dinitrophenol
2,4-dinitrophenol wa® purified hy 
recrystallisation from water, followed by sublimation
at 80°G and 0.1 mm. pressure. The melting point of
o 76
the final sample was 111-113 C (literature value ,
113°C).
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Measurements
The first dissociation constant of the 
acids was usually determined "by titration of solutions 
of the acid in sodium hydroxide solution with perchloric 
acid, though with some of the more soluble acids 
the organic acid solution was titrated directly 
with alkali. The hydrogen ion concentration was 
measured with the glass electrode. Normally, the 
dissociation constant of each acid was calculated 
from the results of at least two titrations, 
preferably at concentrations of organic acid of 5niM 
or greater, and at an ionic strength of 0.10 M.
With the less soluble acids, lower concentrations 
had to be used. Solubility difficulties became 
particularly important in the case of the cresotic 
acids in the 3 M medium, when the dissociation 
constants were calculated from the results of two 
titrations, both with concentrations of acid of only 
2 mM. (More reproducible values of pKa v/ere apparently 
obtained at the higher concentrations of organic 
acid, e.g. 5 and 10 mM.)
The actual method of calculating^8, the 
pKa at each point on the titration curve involved 
substitution of the appropriate values in the equation:
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*27
- log [h *] = pKa + log
the values of [rit] and [RH2] "being derived from 
the considerations that the solution must he 
electrically neutral and that these two species can 
he considered to he the only forms of the organic 
acid present at the pH's in question.
To determine the stabilities of the 
complexes formed hy the acids with ferric ions, a 
solution of ferrous and ferric perchlorate containing 
sufficient perchloric acid to prevent the precipitation 
of ferric hydroxide was "titrated” with a solution of 
the organic acid in alkali. It was found that in 
the initial stages of the titration the addition of 
the solution of the organic acid in excess sodium 
hydroxide caused slight precipitation of ferric 
hydroxide, resulting in slow attainment of equilibrium. 
To overcome this, for measurements at hydrogen ion 
concentrations greater than 10“3*® M, a solution of 
the organic acid in sodium hydroxide was prepared 
and the excess alkali converted to sodium bicarbonate 
by passing carbon dioxide through the solution.
When the hydrogen ion concentration during a titration
? ft
had dropped to 10  ^ M, a solution of the organic 
acid in sodium hydroxide was used instead of the
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bicarbonate solution. Passage of nitrogen through 
the solution in the titration vessel effectively 
mixed the contents and removed the carbon dioxide.
At the same time, an iron solution 
was added from a second burette so as to maintain 
constant values for the total concentrations of 
ferric and ferrous iron in the titration vessel.
After each addition the E.M.F.fs of 
the glass and platinum electrode cells were measured, 
it being usually found that equilibrium had been 
attained after five minutes.
This technique of using sodium bicarbonate
solution to titrate ferric ion solutions without
the formation of a precipitate of ferric hydroxide
was used very successfully by HedstrBm in his
investigation of the hydrolysis of the iron(III)
66ion .
For some of the less soluble acids 
this technique was slightly modified. To a solution 
of ferric and ferrous perchlorate with perchloric acid 
was added a solution of the sodium salt of the organic 
acid. The resultant solution was titrated with a 
solution of sodium bicarbonate or sodium hydroxide, 
depending on the pH, the total iron(II) and iron(III) 
concentrations being kept constant as before.
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RESULTS
1. 5 M Perchlorate
As a result of the theoretical considerations 
mentioned earlier, the stabilities of the different 
complexes formed between the iron(III) ion and the 
derivatives of salicylic acid were investigated in 
a medium made 3 M in perchlorate ion by the addition 
of sodium perchlorate.
Difficulties, however, immediately 
arose caused by the abnormal behaviour of the glass 
electrode. Electrodes immersed in 3 M perchlorate 
solutions displayed drifts of potential of as much 
as 3 per hour. The variation in potential did 
not appear to involve the liquid junction, since 
very constant oxidation-reduction potentials were 
obtained simultaneously. Screening the electrode 
system and storing the glass electrode in an acid or 
alkaline solution did not lessen this drifting of 
potential. Different commercially available glass 
electrodes were tested, but of the limited range 
available, all displayed the same phenomenon.
Considerable time was spent in trying 
to overcome this difficulty, but to no avail.
Some results were obtained for o_-eresotic
acid on two occasions when the drift in potential
appeared to he minimal. These are described below.
o-Cresotic acid
The pKa of £-cresotie acid in a 3 M
perchlorate medium was determined as described
earlier (see Table 3)« The average value of pK under
a
these conditions was 3.20.
In the investigation of the complexes 
formed between iron(III) ions and the acid, apparently 
acceptable results were obtained with two titrations,
i.e. during these titrations the potential of the 
glass electrode remained reproducible, resulting in 
consistent values for the hydrogen ion concentration 
using the experimentally observed value for dE/d(log h) 
of the glass electrode instead of the theoretical 
value of 59*3*6
The difficulties caused by the lack of 
reproducibility of the glass electrode potential 
were aggravated in the complex formation titrations 
by the much greater time (usually three hours or more) 
taken by them, as against the half-hour required to 
carry out a simple acid-base titration. Hence the 
results of only two complex formation titrations 
in 3 M perchlorate are presented here.
One of the titrations was carried out
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by titrating an iron(II)-iron(III) solution, made 
4 mM in hydrogen ion with perchloric acid, with a 
solution of sodium £-cresotate containing a small 
amount of sodium bicarbonate. However, the low 
solubility of £-cresotic acid in 3 M perchlorate 
prevented values of (r h[ /h greater than 0.1 being 
obtained, and the second titration was performed 
by titrating an iron solution containing £-cresotic 
acid with sodium bicarbonate solution. By this 
method it was possible to obtain lower values of h 
and thus higher values of [RH]/h.
The results of the second of these two 
titrations are shown in some detail in Table 2.
By plotting (b-hT )h/[rh] against [rh] /h values 
for Kj and K  ^ can be obtained as described earlier.
In this set of results dE/d(log h) of the glass 
electrode v/as 62.1 m"V. The first value of E in 
the second column is the E.M.F. of the ferric-ferrous 
iron mixture, corrected for the diffusion potential, 
with no £-eresotic acid added but with sufficient 
perchloric acid present (70 mM) in the system to 
depress the hydrolysis of iron.
The values of and obtained are 
shown in Table 4. Each line in the table represents 
a single titration. The graphs are shown in Figure 5*
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Table 2
Determination of the equilibrium conetants of complex 
formation Ki and Ko of o-cresotio acid in 5M perchlorate*
[e]t(mM) E(mV) E&1(mv) h(mli) b [ ™ ] A  (b-k*) h
PET
1*9167
-451.2
-379.5 +40.5 3.263 15.26 0.0722 206.9
1.7149 -371.2 +48 .2 2.456 21.46 0.1036 202.7
1.6025 -365.2 +53.2 2.041 27.36 0.1284 208.6
1.4811 -357.2 +60.2 1.576 37.73 0.1773 208.4
1*3768 -348.0 +68.0 1.181 54.40 0.2550 208.9
1*3053 -339.6 +75.2 0.9051 75.98 0.3578 207.9
1.2373 -329.6 +83.2 0*6735 112.3 0.5111 215.0
1.1500 -310.9 +98.8 0.3784 233.7 1.0102 225.6
* The number of figures in each term in the Table is greater 
than that warranted in fact in order not to introduce 
an appreciable error into the calculations*
Table 3
The carboxylic dissociation constant of 
o-oresotic acid in 3M perchlorate medium
Initial conon. of 
o-cresotic acid
1.963
2.395
M  (mM) Drh"] (mM) £Ka
0*1283 1.408 0.2838 3.20
0.1574 1.342 0.3326 3.20
0.1880 1.279 0.3783 3.20
0*2204 1*220 0.4208 3.19
0.2488 1.159 0.4658 3.21
0.2840 1.106 0.5025 3.20
0.3181 1.054 0*5389 3.21
0.3563 1.008 0.5699 3.20
0.3886 0.9572 0,6054 3.21
0.4224 0.9096 0.6382 3.22
0.4641 0.8715 0.6617 3.21
Average 3.20
0,1426 1.756 0.3821 3.18
0,2300 1.54-3 0,5284 3.17
0,3151 1.346 0.6628 3.19
0.3462 1.287 0*7019 3.20
0.4509 1.131 0*7998 3.20
0,5550 0.9897 O.8869 3.21
Average 3.19
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II* 0.1 M Ionic Strength Medium
The difficulties experienced through the 
abnormal behaviour of the glass electrode in 3^  
perchlorate solution caused the whole question of the 
medium to be used to be re-examined. It was decided 
that an accurate measure of the hydrogen ion concentration 
was of greater importance than minor variations in 
the liquid junction potential and activity 
coefficients, and hence it was decided to work in a 
medium containing a very much lower concentration 
of inert salt. This would, of course, introduce the 
difficulties with liquid junction potentials and 
activity coefficients mentioned above, but by working 
with low concentrations of ferric ion the changes in 
ionic strength resulting from the alterations in 
ferric ion concentration were minimised.
By using an ammonium nitrate bridge between 
the electrodes and the saturated calomel electrode 
it was assumed that the liquid junction potential 
of the cell was kept approximately constant, ammonium 
nitrate possessing approximately equal anion and 
cation conductances. However, at higher hydrogen ion 
concentrations deviations from this behaviour were 
noted. In Figure 6 is plotted (against the hydrogen
- 5 5 -
ion concentration) the ohserved values of the
oxidation-reduction potentials of a solution of
ferric, ferrous, hydrogen and perchlorate ions in
which the ionic strength and the ratio of the concentrations
of total ferric to ferrous iron were kept constant.
It is seen that on increasing h, the observed E.M.F. 
initially rises to a maximum, and then decreases.
The initial rise is caused by the increase in ferric
ion concentration with h resulting from the decreased
IIIconcentration of hydrolysis products of the Fe ion.
The decrease in potential at values of h greater 
than 33 ^  is probably caused by the increasing 
influence of the liquid junction on the observed 
E.h.F. The value of the maximum at h = 33 was 
taken to be E0.
This assumption is open to question, since 
the liquid junction potential may well be significant 
at h — 33 nil* thus producing an apparent value of E0 
less than the correct value. However, the value 
taken for E0 is not critical, an error of as much 
as 3 producing a deviation of only lift in the 
calculated value for K^. Furthermore, the values of 
obtained using this assumption agree well with 
values obtained by other methods.
In determining the contribution of
-56-
525-
ob«.
(»V)
520-
515
50 IOO
h(mM)
Fig. 6. The effect of hydrogen ion concentration 
on the apparent oxidation-reduction 
potential (versus the saturated calomel 
electrode) of a solution of iron(III) 
(0.36mM) and iron(II) (O.l^niM) at ionic 
strength 0.1.
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hydrolysis products of iron(III) to the oxidation- 
potential ?
reduction/, the values of k-^ and k22 (2*9 x ^  ^
and 1.4 x lO"’-' M respectively) obtained or derived
from the work of Kilburn and VosburghT^ were used.
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Hedstrdm had determined a value for k^g in 3 ^
perchlorate, and from this value an estimate was
—6 2made of k12 in ionic strength 0.1 of 2.8 x 10 M .
faking into account the above considerations, 
the complex formation between iron(III) and a number 
of phenolic compounds was investigated. The results 
obtained are presented in the following pages.
o-Cresotic acid
The pK0 of the carboxylic group of thisci
acid was found to be 2.82 (see Table 5)» Only two 
points in the titration of the 10 mM solution v/ere 
obtained before precipitation of the acid occurred.
Average values of and K2 of 3^3 a11^.
2.9 respectively were found (see Figure 10 and 
Table 7).
In some earlier experiments at high 
hydrogen ion concentrations (10“  ^ to 10~^ M) in 
which ferrous-ferric solutions had been titrated directly 
with sodium £-cresotate, it had been noted that the 
results could be explained on the basis of the 1:1
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complex alone "being present, i.e. a straight line 
resulted on graphing (b-h1) against [an] /h. The 
value of obtained from these titrations was 
somewhat higher than that found at lower values of 
h (h less than 1 mM) but it was considered that this 
error might arise from the inconstancy of the liquid 
junction potential, although the glass electrode 
standardisation did not alter even up to hydrogen 
ion concentrations of 10 mM.
Salicylic acid
Two titrations of 2.5 and 20 mM solutions 
gave a value of 2.82 for the pK of the acid in aa
solution of ionic strength 0,1 (see Table 5)-
Part of the titration eurve obtained in the titration
of the 2.5 mM solution is shown in Figure 7»
The values of Kj and K2 for salicylic 
acid were determined in a similar way to those of 
£-eresctie acid, though, as a result of the greater 
solubility of salicylic acid in water, the iron 
solution was titrated directly with a solution of 
sodium salicylate containing an excess of alhali in 
the form of sodium bicarbonate. The results of three 
titrations carried out in this way are shown in 
Figure 11 and in Table 7- i'ke average values K
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equal to 820 and r: 17 were found.
m-Cresotic acid
From the results of two titrations 
of 5 and 10 mM solutions of m-cresotic acid, a value 
for the pKa of the acid of 2.97 was obtained (Table 5)* 
Average values of and K2 of 980 and 17 
respectively were found (see Table 7 and Figure 12).
p-Cresotic acid
Titration of 5 and 10 mM solutions of 
2>-eresotic acid in excess alkali with perchloric 
acid gave an average value of pKa of 2.9O (Table 5)*
The average values of and K2 obtained 
were 94-8 and 18 respectively (see Figure 13 and 
Table 7)•
6-Methylsalicylic acid
This acid was markedly more soluble 
than the other methylsalicylic acids, considerably 
easing practical difficulties during the titrations 
caused by low solubility.
The average value of the pKc of thecl
carboxylate group was found to be J.l6 (see Table 5)* 
Average values for K2 of 3Si
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and 4.6 respectively were obtained (see Figure 14 
and Table 7).
5-iso-Propylsalicylic acid
The main difficulty with this particular 
compound lay in the low solubility of the acid itself 
in water, though solubility difficulties were not 
experienced with the sodium salt of the acid. As 
a result of this, it was possible to obtain values 
of the oxidation-reduction potential and hydrogen 
ion concentration over only a limited range of 
conditions before either a solid phase of ferric 
hydroxide or 5-iso-propylsalicylic acid was present 
in the solution. At the low pH*s at which the 
measurements had to be made only the 1:1 complex 
was formed in significant amount, and the value of 
was obtained from the gradient of the graph of 
(b-k1) against [Rii]/h.
The dissociation constant of the acid 
was determined by titration of a 10 mM solution of 
the sodium salt with perchloric acid (Table 5).
The value of the pKa obtained, 2.76, was checked by 
titration of a 5 mM solution of the salt. Although 
this second titration confirmed the value of 2.76,
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the pKa values obtained in it v/ere not as constant 
as in the first titration, and they are not reported.
Only a few values of h and the oxidation- 
reduction potential were measured in each titration 
of the ferric-ferrous solution with sodium 
5-iso-propylsalicylate before ferric hydroxide was 
precipitated. Thus the value of Kj_ obtained (350) 
was very approximate (see Figure 15 and Table 7)*
#-Resorcylic acid
The dissociation constant of the 
carboxylic group of this acid was determined by 
titration of 10 and 20 mM solutions of the sodium 
salt with perchloric acid. From these titrations the 
value of the pKa was taken to be 1.07* this particularly 
low value showing the strong acidity of the carboxylic 
group of this acid (see Table 5)-
In the complex formation titrations, 
average values of and K2 of 573 &ncl l6 respectively 
were obtained (see Figure l6 and Table 7)*
^-Resorcylic acid
To determine the dissociation constant 
of the carboxylic group of/-resorcylic acid, 16,
20 and 27 mM solutions of sodium /J-resorcylate were 
titrated with perchloric acid. An average value for 
the pKa of was obtained (see Table 5)* By
titration the pICa of the more acid of the two phenolic 
groups was found to be approximately 8.5» But since 
this was well outside the range of pH in which 
measurements were made, and therefore the contribution 
of hydrogen ion from this source negligible, its 
value was not measured accurately. Part of the 
titration curve obtained in the titration of the 
l6.5 mM solution of sodium^-resorcylate is shown 
in Figure 8.
The equilibrium constants of complex 
formation were obtained in the usual way, From 
two titrations average values of K-^  and of 1340
and 58 respectively were obtained (see Figure 17 
and Table 7)•
Salicyluric acid
The pKa of the carboxylic group was 
found by titration to have an average value of 
3.41 (see Table 5)* Similarly an approximate value 
of 8.2 was obtained for the pKa of the phenolic group. 
Part of the titration curve of one of the titrations 
is shown in Figure 9*
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Investigation of the purple complex 
of salicyluric acid with iron(III) ions by Jobfs 
Method of Continuous Variations spectrophotometrically 
indicated that it was essentially similar in type 
to those of the £-hydroxybenzoic acids, consisting 
of ferric ions and salicyluric acid ions in the 
molar ratio 1:1.
The complexes formed between ferric 
ions and this acid were also investigated 
potentiometrically using the same technique as was 
used with the other derivatives of salicylic acid.
The results obtained fitted the same pattern, values 
of and K2 of 121 and J.8 respectively being 
obtained (see Figure 18 and Table 8).
At low values of [rh] /h in the graph 
of (b-k1 )h/ [rh] against [mi] /h deviations from 
linearity towards higher values were noted. These 
results are apparently explained on the assumption 
that a complex FeRH2* is being formed. In that case 
a further term .h would have to be introduced 
into the expression:
resulting in:
+  K +  K2M L  +  ^ I S g L 2W  = Kl'.n + kx +
where
* -  , _  CgeRlJ
1 [l-'e] [rh]
At low pH's the last term in the above 
equation will be negligible, and in the event of
?4-the species FeRHc being present, a straight line 
should result on graphing £( b-k* )h/ [rh] - K2[RH]/h| 
against h. A linear relation was observed in the 
case of this compound, giving an average value for 
K^1 of 7 niM”1 (see Figure 19 and fable 8 - the 
abnormally high value of the ordinate intercept of 
one of the graphs in Figure 19 cannot be explained).
2 ,4-3)initrophenol
The dissociation constant of the phenolic 
group of this acid was measured in the usual way by 
titration of 10 mM solutions of the sodium salt of 
the acid with perchloric acid. An average value 
for the pK of 3*88 was obtained (see Table 6).Q/
On titrating a ferrous-ferric solution 
with the sodium salt of 2 ,4-dinitrophenol, there 
was no evidence of complexing of the iron from the 
pH or oxidation-reduction potential measurements, 
nor from any obvious colour changes. It would
-65-
appear that any complexing of the phenol is masked 
by the formation of hydroxyl complexes with the iron. 
Errors in the values of the formation constants of 
the ferric hydroxyl complexes are of a similar or 
greater order to the degree of complexing of the 
ferric ions by the phenol.
Thus, by comparison with the previous 
phenolic acids, the complexing power of 2,4-dinitrophenol 
with ferric ions is negligible.
5-Phenylsalicylic acid, 5-tert-butylsalicylio acid, 
and gentisic acid
It had been hoped to obtain data concerning 
the complexing power of the above acids towards 
ferric ions, all three forming the typical purple 
or blue colour of solutions of £-hydroxybenzoic 
acids with ferric ions. However, the very low 
solubilities of the &ncL 5-tert-butyl- acids
in water prevented quantitative examination of either 
their strengths or their complexing power.
Gentisic acid was found to be too 
readily oxidised by ferric ions for any measurements 
of its complexing power to be made.
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Summary
The results obtained in.tt medium of 
ionic strength 0.1 M are shorn in Table 9»
While there was evidence that the eompl 
FeR^5” was formed by most of the acids, it was not 
possible to make any assessment of the value of K^. 
It should be noted that the accuracy of measurement 
of K£ was considerably less than
Table 5
The carboxylic dissociation constants of 
the acids in 0«1 M ionic strength
Initial concn. of 
organic acid (mM;
2,396
2,934
Gs*](inM) EBIiTfroM) [pjij (mM) 
o-cresotic acid
PKa
0,3936 1.6906 0,4018 2.78
0,4842 1.5874 0.4691 2.79
0,5888 1.5048 0.5170 2.77
0,6761 1,4111 0.5771 2.78
0.7674 1.3273 0.6285 2.79
0.8610 1.2514 0,6730 2.80
0.9550 1.1813 0.7126 2.80
1.047 1.1143 0.7502 2.81
1.175 1.0881 0.7478 2.77
Average 2.79
0.2163 1.8692 0.2892 2.86
0,2818 1.7794 0.3502 2.8!*.
0.3673 1.6643 0.4281 2.85
0.4519 1.5551 0.5014 2.85
0.5433 1.4593 0.5625 2.85
0.7328 1.2927 0.6631 2.85
0.8318 1.2222 0.7022 2.8t
0.9226 1.1489 0.7450 2.85
1.019 1.0863 0,7782 2.85
Average 2.85
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Initial concn. of
organic aoid (mM)
10.11
2*538
20.07
Table 5 (contd.)
Erh*L] Cbm) [rH^ (mM)
o-creaotic acid (contd.)
0.3981 7.6441 2.0036 2.82
0.4875 7.2630 2.3389 2.82
Average 2.82
salicylic acid
1*355 1*355 • 1.183 2.81
1*169 1.408 1.069 2.81
0.9954 1.461 0.9560 2.81
0.9016 1*499 0.885k 2.82
0.8110 1.536 0.8143 2.82
0.7245 1*573 0.7470 2.82
0.6412 1.611 0.6757 2.82
0.5610 1*647 0.6077 2.82
0.4159 1*729 0.4684 2.81
Average 2.82
0.3034 15.49 3*180 2.83
0.3784 14.79 3.745 2.83
0.5070 13*66 4,663 2.83
0.6622 12.59 5.532 2.82
0.8318 11.55 6.364 2.82
1.019 10.56 7.154 2.82
1.236 9.630 7.894 2.82
1*496 8.764 8.571 2.82
1.778 7.944 9.206 2.81
Average 2.82
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Initial concn. of
organic acid C mMT
10.11
2.538
20.07
Table 5 (contd.)
.H*] (m) ErH~D fmM'i [rH21 (mM) 
o-cresotic acid (contd.)
0.3981 7.6441 2.0036
0.4875 7.2630 2.3389
Average
salicylic acid
1*355 1*355 • 1.183
1*169 1.408 1.069
0.9954 1.461 0.9560
0.9016 1*499 0.8854
O.811O 1.536 0.8143
0.7245 1.573 0.7470
0.6412 1.611 0.6757
0.5610 1*647 0.6077
0.4159 1.729 0.4684
Average
0.3034 15.49 3.180
0.3784 14.79 3.745
0.5070 13*66 4.663
0.6622 12.59 5.532
0.8318 11.55 6.364
1.019 10.56 7.154
1.236 9.630 7.894
1.496 8.764 8.571
1.778 7.944 9.206
Average
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pKa
2.82
2.82
2.82
2.81
2.81
2.81
2.82
2.82
2.82
2.82
2.82
2.81
2.82
2.83
2.83
2.83 
2.82 
2.82 
2.82 
2.82 
2.82 
2.81 
2.82
Tniiial concn. of
organic acid (mM)
5.039
9.916
5.2136
Table 5 (oontd.) 
m-oresotio acid
0.2512 3. 686
0.3273 3.446
0.4046 3.218
0.4898 3.005
0.5781 2.800
0.6761 2.617
0.7762 2.440
0.8810 2.276
0.9772 2.110
0,2891 6.761
0.3483 6.421
0,3802 6.255
0.4150 6.094
0.4467 5.931
•p-cresotic acid......
0.2951 3.837
0.3784 3.602
0.4345 3.452
0.4943 3.308
0.5508 3.165
0,6486 2.969
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[HHgl (mM) pKa
0.8737 2,97
1.054 2.97
1.221 2.97
1.376 2.97
1.529 2.98
1.653 2.97
1.779 2.97
1.888 2.97
2.003 2.99
Average 2.97
1.824 2.97
2.090 2.97
2.220 2.97
2.345 2.97
2,472 2.97
Average 2.97
0.9028 2.90
1.073 2.90
1.183 2.90
1.285 2.90
1.389 2«9°
1.525 2*9°
Tnitial concn. of
organic aoid (mM)
10*11
5*093
gable 5 (contd.)
Ekh"!] (mM) (mM)
p-oresotic acid (contd.)
0.7499 2*785 1.652 2*90
0*9594 2.444 1.883 2.90
1*079 2.299 1.975 2.90
Average 2.90
0*3373 7.206 1.945 2.90
0*4027 6.855 2.220 2.90
0.4786 6.512 2.476 2.90
0.5495 6.176 2.733 2.91
0.6745 5.705 3.089 2.90
0.8110 5.259 3.420 2.90
0.9550 4.836 3.733 2.91
1.122 4.451 4.011 2,90
1,486 3.750 4.504 2.91
Average 2*90
6-methylsalicvlic acid
0.1730 3.684 0.9242 3.16
0.2254 3.422 1.124 3.16
0*2851 3.176 1.310 3.16
0.3467 2.940 1.488 3.16
0.4169 2.720 1.651 3.16
0.4932 2.513 1.802 3.16
0.5754 2.320 1.942 3.16
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Tnltial concn. of
organic acid (gST
9.984.2
9.954-
20,81
Table 5 (contd.)
[#*](”#■) [BHjCmM) ^
6*^ nethyl3alicylic acid (contd.')
0.6683 2.126 2.079 3.17
0.7603 1.974 2.184- 3.16
Average 3.16
0*1995 7*012 1.983 3.15
0*264-9 6.455 2.420 3.15
0*3388 5.923 2.835 3.15
0.4-236 5.417 3.228 3.15
0*5188 4.937 3.597 3.15
0*6281 4-* 486 3.939 3.15
0*7516 4-. 066 4.254 3.14
0.8913 3.668 4.549 3.14
1.227 2.976 5.043 3.14
Average 3.15
Viso-nroovlsalicylic acid
0.3228 7.645 1.420 2.7 6
0.3614 7.470 1.554 2.76
0.4-188 7.231 1.736 2.7 6
0.4-592 7.062 1.865 2.76
0*4-977 6.893 1.994 2.7 6
Average 2.7 6
T'-resorcylic acid
2,767 18.80 0.610 1.07
3.296 18.58 0.695
1.06
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Initial concn. of
organic aoid (nSTT
10,21
20*30
Table 5 (contd,)
Di4] (mM) |jRH"](mM) [rhJ  (mM) 
^-resorcylic acid (contd.)
3.77 6 18.32 0.821
4.236 18.05 0.958
4.764 17.86 1.018
5.272 17.66 1.091
Average
2.897 8.681 0.3162
3.350 8.538 0.3418
3.758 8.366 0.3995
4.188 8.230 0.4239
4.624 8.115 0,4304
Average
fi'-resorcylic aoid1
0.2291 14.61 4.187
0.2938 13.63 4.997
0.3631 12.67 5.787
0.4467 11.74 6.547
0.5370 10.84 7.285
0.6383 9.970 7.998
0.7586 9.133 8.677
0.8913 8.324 9.331
1.047 7.556 9.947
1.233 6.833 10.52
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Average
1.07 
1.10
1.08
1.07
1.07 
1.10
1.08 
1.10
1.09 
1„06
1.09
3.10
3.10
3.10
3.10
3.10
3.10
3.10
3.10
3.10
3.10
3.10
Initial concn, of
organic acid (mM)
16.47
26.79
10.52
Table 5 (contdo)
&H"3.(iriM) JjiH J  (mM) pKa
^-resorcylic acid (contd.V
0.2291 11.59 3.523 3.12
0.2884 10.82 4.772 3.12
0.3606 10.07 4.772 3.12
0.4385 9.340 5.365 3.12
0.5224 8.635 5.940 3.12
0.6194 7.956 6.491 3.12
0.7328 7.306 7.015 3.12
0.8550 6.677 7.521 3.12
1.000 6.083 7.993 3.12
Average 3.12
0.2553 17.23 5.280 3.08
0*3388 15.86 6.370 3.07
0.4315 14.53 7.422 3.07
0.7907 10.89 10.29 3.08
Average 3.08
salicyluric acid
0.1151 7.742 2.302 3.41
0.1535 7.158 2.815 3.41
0.1963 6.588 3.315 3.41
0.2466 6.034 3.800 3.41
0.3034 5.494 4.271 3.41
0.3724 4.975 4.722 3.41
0.4571 4.480 5.151 3.40
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Tnitial oonon. of
organic aoid (mM1)
21.01
Table 5 (oontd,)
M W  [RH?](mU) ^a
salicyluric aoia (contd.)
0.5495 4.001 5.565 3.40
0.6622 3*549 5.951 3.40
0.7980 3.129 6.308 3.40
Average 3.41
0.1567 13.39 5.529 3.42
0.1941 12.40 6.317 3.42
0.2393 11.43 7.080 3.42
0.2891 10.49 7.820 3.41
0.3467 9.573 8.535 3.41
0.4150 8.691 9.224 3.41
0.4932 7.840 9.886 3.41
0.5902 7.027 10.51 3.40
0.7047 6.250 11.11 3.40
0*8414 5.513 11.67 3.40
Average 3.41
-75-
Table 6
The dissociation constant of
2. 4~&initrophenol in 0'.1 M ionic strength
Initial concn. of r n 
4-dinitrophenol (mM) LH J(mM) Df](nd£) M ( b m )
10.04 0.02679 7.444 2.120
0.05152 6.849 2.61,6
0.06887 6.256 3.173
0.08872 5.674 3.689
0.1096 5.101 4.197
0.1274 4*748 4.510
0.1387 4*545 4.689
0.1738 4*003 5.168
9.939 0.04864 6.804
Average
2.572
0.07047 6.017 3.271
0.09863 5.257 3.953
0.1321 4.505 4.612
O.1816 3.790 5.245
0.2483 3.105 5.849
0.3451 2.464 6.410
Average
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£Ka
3.88
3.88
3.87
3.87
3.88
3.87
3.87
3.87
3.87
3.89
3.89
3.88
3.89 
3.88 
3.88 
3.88 
3.88
Table 7
The equilibrium constants of complex formation of the substituted 
salicylic acids with iron (ill) ions in ionic strength 0.1M
Symbol [ge11] (m) [ge111! (m) MfiaM) Kg Kg
o-cresotic acid
+ 0.75 0.28 3.9 390 3.9
X 0.076 0.18 2.7 375 1.9
Average 383 2.9
salicylic acid
□ 0.15 0.36 3.6 900 18
0 0.76 0.28 3.9 740 10
X 0.15 0.36 3.6 820 22
Average 820 17
m-oreaotic acid
X 0.15 0.36 3.6 950 14
0 0.15 0.36 3.6 1010 22
□ 0.76 0.28 3.9 980 15
Average 980 17
p-eresotio acid
X 0.15 0.36 3.6 950 17
0 0.76 0.28 3.9 945 18
Average % 8 18
Table 7 (Contd,)
ymbol [je11] (mM) [pem ](mM) [H+](mM) El Eg
6-methylsalicylic acid
X 0*76 0.28 5.4 394 4*6
0 0.76 0.28 3.9 373 4.2
□ 0.15 0.36 4.1 377 4.7
Average 381 4.6
3-i s o-propyl sailcyl i c acid
X 0.15 0.36 4*1 370
0 0.76 0.28 3.9 340
Average 350
^-resorcylic acid
0 0.76 0.28 3.9 565 17
X 0.15 0.36 4.1 580 15
Average 573 16
& -resorcylic acid
0 0.76 0.28 3.9 1360 57
X 0.15 0.36 4.1 1320 59
Average 1340 58
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Fig. 7- Partial curve obtained in the titration of 
20 ml 2.538 mM salicylic acid with 9*79 “M 
sodium hydroxide (Ionic strength 0.1).
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2-
ml acid added
Fig.8. Partial curve obtained in the titration of 
40 ml 16.47 nifvl p  -resorcylic acid in 19.57 
mM sodium hydroxide with 79*9 perchloric 
acid (Ionic strength 0.1).
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8N
ml acid added
Fig. 9. Partial curve obtained in the titration of 
40 r a l  21.01 mM salicyluric acid in 23.48 mM 
sodium hydroxide with 79*9 eM perchloric 
acid (Ionic strength 0.1).
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Fig. 11. Salicylic acid. Determination of Kx and K2.
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DISCUSSION,
Tlie ionisation constants of the acids studied.
The importance of structural and 
electronic effects on the dissociation constants of 
organic acids is by now well established. In that 
connection the values of the carboxylic dissociation 
constants of the acids studied relative to that of 
salicylic acid follow the expected pattern, though 
a few points of interest arise from s consideration 
of the 3— and 6- substituted salicylic acids.
fhe methyl group in the position para 
to the carboxyl in a-cresotic acid increases the 
electron density in the carboxyl group, with a 
resultant stabilisation of the unionised form of the 
acid and decrease in its strength relative to 
salicylic acid. Electron repelling substituents 
in the 5-position would be expected to weaken the 
acid by opposing the ionisation of the proton by 
the mechanism indicated;
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This effect is noted with 5-methylsalicylic acid. 
(p_—cresotic acid), and is even more marked where 
the substituent is a hydroxyl group, as iny^-resorcylic 
acid. The abnormally high strength of y-resorcylic 
acid is explained if it is assumed that the anion 
is stabilised by hydrogen bonding of both carboxyl 
oxygen atoms to the phenolic hydrogensresulting 
in considerable resonance stabilisation:
It is perhaps of interest to note that the I.E. 
spectrum of methyl Y-resorcylate in carbon 
tetrachloride indicates the presence of two types 
of hydrogen bond, presumably those indicated
The abnormal results in the cases of 
the 3- and 6- alkylsalieylic acids can only he
explained when steric considerations are taken into 
account. The 3-methyl substituent might have been 
expected to have a similar weakening effect on the 
acid, strength to 5-methylsalicylic acid. In fact, 
it has the same dissociation constant as salicylic 
acid;, and the bulkier 3-iso-propyl group in 
3-iso~prop.vlsalic.vlic acid results in an even 
stronger acid. It would appear that in the 3-methyl 
compound there are two; opposing effects which balance 
each other out: the electronic effect of the methyl
group ortho to the phenolic group tending to weaken 
the acid, and, the same substituent1s steric effect 
tending to strengthen the acid. In 3-iso-propylsalicylic 
acid the steric effect of the larger group is much 
greater than the opposed- electronic effect, the nett 
result of these being a strengthening of the acid. 
Comparison of the 4- and 6-methylsalicylic acids 
indicates that electronic effects alone do not 
explain the stabilisation, of the unionised acid in 
the 6-methyl-derivative: here, too, a steric effect 
would appear to be active, in this case causing a 
weakening of the acid.
It is at this point pertinent to consider 
investigations of the infra-red spectra of these
sterically hindered compounds. Hunsberger and
rj O
co-workers in a study of some compounds containing
the salicylic acid grouping found that there was
a decrease in the carbonyl frequency in those
compounds in which a methylene or methyl group was
adjacent to the carboxyl. Apparently hydrogen
bonding is enhanced in these compounds, and the
authors suggested that an explanation for the
phenomenon was that the bulk of the adjacent
methylene or methyl group pushed the carbonyl
oxygen closer to the hydroxyl group than was the
case in the other compounds. They used the term
11 steric facilitation of chelation1' to describe
79this. Brooks, Eglinton and Morman examined 
the infra-red, spectra of a considerable number of 
substituted salicylic acids and found that alkyl 
substitution in the 3- and particularly in the 
6-position led to lower carbonyl frequencies 
relative to that of salicylic acid itself, the 
displacement increasing with bulk of substituent 
(see fable 10-).
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Table 1®.
pKft and carbonyl stretching frequencies (cm-1) (CC1.) 
in some substituted salicylic acids.
Acid V q q(monomer)
Salicylic acid. 2.82 1698
4-Methylsalicylic acid. 2.97 1697
5-metbylsalicylic acid. 2.90 • 1698
3-Meth.ylsalicylic acid. 2.82 1695
3-is£-Propylsalicylic acid. 2.76 1693
3-tert-Butylsalicylic acid. - 1691
3-Pbenylsalicylic acid. - 1695
6-Metliylsalicylic acid. 3.16 1686
6-Ethylsalicylic acid. — 1683
m. this work
not measured
They ascribed the effect of the 3-alkyl 
groups to compression of the phenolic hydroxyl group 
with probable reduction in the 0— H...0 distance. 
This should cause strengthening of the hydrogen 
bond and resultant stabilisation of the anionic form 
of the acid. The observed. pK^s are in agreement 
with this.
However, with 6-methylsalicylic acid, 
although the carbonyl frequency is markedly lower 
than with salicylic acid, the pK is greater. Thus, 
in this case we have the apparently anomalous result 
of enhanced hydrogen bonding, which would be expected 
to stabilise the anion, coupled with a weaker acid. 
Peltier and Dippy and his collaborators had 
previously measured the dissociation constant; of 
6-methylsalicylic acid, and had suggested that its 
abnormally low value resulted from inhibition of 
intramolecular hydrogen bonding through steric 
factors. However, it should be noted that the 
infra-red measurements were made on the unionised 
acid dissolved in carbon tetrachloride, whereas the 
dissociation constants were measured in aqueous 
solution, and Brooks and co-workers suggested that 
“in the solvated resonance stabilised anion small
deviations from coplanarity could lead to relative 
destabilisation with, consequent weakening of the 
acid”.
As might he expected, the pK ofa
salicyluric acid, 3*41 in an ionic strength of 0.1M, 
is intermediate in magnitude between those of acetic 
acid ( 4 . 8 ) and glycine (2.35)^2. In solution 
the salieylurate ion will be stabilised to some 
extent by electrostatic attraction between the 
partial positive charge on the nitrogen atom and the 
negatively charged carboxylate group:
The effect of this stabilisation will 
not, of course, be nearly as great as that obtained 
in glycine, where the negative charge on the 
carboxylate group is stabilised by a whole positive 
charge on the nitrogen atom:
In these cases it is unlikely on 
steric grounds that there is any marked hydrogen 
bonding between the negatively charged oxygen 
atom and the positively charged NH^ group, strong 
hydrogen bonds not being formed with completion of 
a, five-membered ring^.
The dissociation constant of hippuric 
82acid (pKa =3*64) is close to that for salicyluric 
acid found in this work (pK - 3.41), and correction 
of the latter to the thermodynamic value would bring 
it even closer to that for hippuric acid. Apparently, 
therefore, the presence of the phenolic group in 
salicyluric acid has little influence on the 
dissociation constant of the carboxylic group.
The high acidity of the lask compound 
of this series, 2,4-dinitrophenol, does, of course, 
arise from the stabilisation of the phenolate ion 
by the electron-withdrawing nitro-groups in the 
2- and 4- positions.
Comparison of the equilibrium constants of complex
formation with those of other workers
As stated earlier, only the complexes of 
salicylic acid,^ -resorcylic acid, and m-eresotic 
acid with iron(III) have been studied quantitatively 
before in aqueous solution, though the complexes of 
some of the other acids have been studied in
aleohol-water m i x t u r e s ^
In recent years a number of workers 
have investigated the equilibria in solutions of 
ferric ion and salicylic acid, mainly using photometric 
methods. All the papers listed below in Table 11, 
with the exception of Babko’s, published in 1945» 
have been published since 1952. There have, of 
course, been a number of other workers who have 
investigated the system in a more qualitative way,
but their results are not included.
It should be noted that the equilibrium
constants calculated from Perrin's59 work are in
fact equivalent to the function
|>e% 0 0 ”
M B
where n = 1 or 2, since his glass electrode was 
used to measure hydrogen ion activity rather than
Table 11
Previous investigations of equilibrium constants of 
QPerplexes of iron (ill) with salicylic acid in aqueous solution
Ref. S . *2 a *7
Method Tenro (°C) IonicStrength
51 1000 11 2 x 10 7 photometric ? 0.01
52 1120 photometric 15 3.6 x 10~:
53 500 18 8 x 10"'*' photometric 25 3.0
53 470 15 1.5 x 10Wf potenti ometrie 25 3.0
54 520 0 .4 1.6 x 10"6 photometric 18 0.25
59 550 11 potenti ometrio 20 0.15
56 1200 52 5 x 10-5 photometric 20 0.25
57 1070 24 photometric ? ?
58 1100 photometric ? 0.1
This
Work 820 17
potenti ometric 25 0.1
Note:- Some of these values have been recalculated in 
terms of Kj, and Kj from the author1 s data
concentration. Thus, to make his results strictly 
comparable with bhose of this work, an activity 
correction should, he introduced.. At an ionic strength 
of 0.15 M, the activity coefficient of the hydrogen 
ion is approximately G.72, and hence more comparable 
values of and Kg are 7^0 and 21 respectively.
On the whole, considering the wide 
range of conditions in which the measurements have 
been made, agreement between the different values 
of K]_ and K£ is quite good.
The values obtained by previous workers 
of the constants for ^ -resorcylie acid and m-cresotic 
acid are given in Tables 12 and 13.
It is seen that the constants for 
^-resoreylic acid and m-cresotic acid recently 
reported by Tsin Jao, Sommer and Okac^ are in 
particularly good agreement with those obtained in 
this work. These workers investigated a number of 
substituted salicylic acids, including salicylic 
acid, ^ -resorcylic acid, y-resorcylic acid and 
m-cresotic acid, as regards their complexing power 
with iron(III), but unfortunately most of their 
measurements were made in aqueous ethanol and cannot 
be directly compared with results in aqueous solution.
Bobtelsky and Kertes^ examined the
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Table 12
Previous investigations of equilibrium constants of 
complexes of iron. (Hi) with^ —resoroylio acid in aqueous solution
Ref, E l Kg a Method Temp
62 720 13 3 x  10"^ photometric ?
58 1550 M photometric ?
This
Work 1340 58 potentiometric 25
Strength
?
0.1
0.1
Table 13
Previous investigations cf equilibrium constants of* 
complexes off iron (ill) Ydth m-cresotic aoid in aqueous solution
« /0„\ Ionic
Ref. Ki Kg Method T«gE,LJ£)
58 1050 - photometric ? 0.1
980 17 potentiometrio 25 0.1
Work
- 1 0 0 -
complexes of 2,4-dinitrophenol with iron(lll) in 
aqueous alcohol. Two complexes, FeR and FeR^, were 
detected. However, even in alcoholic solution their 
stabilities were not great.
jj3-e relative stabilities of the complexes of the 
substituted salicylic acids.
Many authors have attempted "to correlate 
the proton dissociation constants of ligands with the 
dissociation constant of the corresponding metal-ligand 
complex;. In 1934 Larsson^ showed that there was a 
linear relation between the logarithm of the 
stability constant of some silver(I)-diammines (in 
aqueous ethanol) and the pK^j of the ammine ligand
Q/T
(in water). Following Calvin and Wilson's paper
Qry
in 1945* a number of workers have studied this 
relationship , and the conclusion can be drawn that 
only an approximate linear relation holds, and that 
only between structurally similar ligands fftrming 
structurally similar metal ion complexes.
ren^® showed that a plot of pK^
against P^n> where
kn = rFe] [n]n , n = 1 or 2,
for the compounds salicylic acid, 5—sulphosalicylic 
acid, and p-aminosalicylic acid (4-aminosalicylic acid), 
resulted in straight lines of gradient 1 and 0.5 
respectively with equation
n.pKa2 = P*n + A'
- 1 0 2 -
where K&2 is the phenolic dissociation constant and 
is defined by
“1^]^ (HH 5 salicylate ion) 
and A* a constant.
Hence Ka^ - k^ x: constantn
nEor constant « a2 - y
2 n
n
Thus he concluded, that substances falling on the
same straight line have about the same value of K
n
and the same standard free energy change,
tt *
- A G  = EI I n K n
for the reaction.
Pe 4- nHH nH 4 PeRn
It would be expected, therefore, that 
all the compounds studied in this work, with the 
exception of 2,4-dinitrophenol and salicyluric 
acid, would possess a similar relationship between 
the phenolic dissociation constant and the dissociation 
constant of the complex, i.e. equal values of K^.
However, although most of the values of E-^  and K2
are of a similar order of magnitude, there are 
differences which are greater than experimental
error. These differences between the values
corresponding constants 
of i^=aEE±=fig/for salicylic acid and those for the
substituted salicylic acids can be explained in terms 
of resonance or steric effects.
Duncan^ *S1 derived a thermodynamic
relation
(W > ~ %L°log Ka = pK - -----------  + b
8 a 2.303RT
where Ks is the stability constant of a series of 1:1 
complex ions, ML, derived from one metal, M, with a 
set of similar ligands, 1 , and pK is the negative 
logarithm of the dissociation constant of HL. %n° 
and Gjjj,0 are the partial molar free energies of the 
species ML and HI respectively, and B is a constant 
independent of L.
This can be rearranged to
%L° ~ %1°
10S{IW  =  2: & g ~  +  B
i,e* log K-i = ^  +  B  i f
g 1 2.303RT
Ks.Ka =
This last assumption is not, of course, strictly 
correct, since Kj_ is not a thermodynamic constant. 
However, this does not affect the argument which follows.
In the event of the dependence of ®HL 
upon the ligand being similar to that of G-^ , log
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will be constant. However, should the metal ion 
complex be stabilised to a greater extent than the 
proton-ligand complex, G~° will be lowered relative 
t^tt. value of log will be greater.
Similarly the converse will be true.
In a similar way it can be shown that for 
the reaction
Pe5+ + nBH" FeBn(5-2a) + hh|
the general equation is
i «  ^  ~ s  +  ^ ,
2.303RT
and the same arguments apply.
Prom a study of the absorption spectra 
of complex ions Williams*^ concluded that many ferric 
complexes are associated with partial charge transfer 
from the ligand to the cation. In a later paper^ 
he and his co-workers suggested that the enhancement 
or depression of the stability of ferric complexes 
relative to the stability of the corresponding 
proton-ligand complex can be correlated with the 
increase or decrease of TT bond acceptance by the 
ferric ion from the ligand. Thus substituents 
increasing the "TT electron density on the ferric 
ion would be expected to increase the stability of 
the cation-ligand complex to a greater extent than
-105-
that of the proton-ligand complex, resulting in an 
increase in the value of K^, whereas those withdrawing 
TT electrons from the ferric ion would be expected to 
have the opposite effect.
of those salicylic acids possessing substituents 
in the 4- and 5“ positions. Both m- and jD-cresotie 
acid have values of K^ significantly higher than that 
of salicylic acid. It will he noted that the methyl 
substituents possess + 1 inductive effects, and so 
will indirectly increase the Tf electron density in 
the chelated ring:
Where the substituent possesses a +M mesomeric effect, 
as does the hydroxyl group in y^-resorcylic acid, the 
'ff electron density in the chelated ring is increased 
even more, with corresponding marked increases in the 
values of and even in Kg fon that acid.
This effect is illustrated well in the case
-106-
A different explanation must be found for
the substantial reduction in K± and K2 for the acids
containing alkyl substituents in the 3- and 6- positions.
This type of phenomenon, namely, that in which a bulky
substituent adjacent to a chelating group reduces
the stability of a metal complex, has been noted by
a number of workers. Irving, Cabell and Mellor92
found that although 2-methyl-1, 10-phenanthroline was
a stronger base than 1,10-phenanthroline, it formed.
weaker complexes with ferrous ions, while the complexing
ability of 2,9-dimethyl-l, 10- phenanthroline with ferrous
ion was negligible. This result they ascribed to steric
hindrance to coordination. Luz, Fallab, and Erlenmayer^J
investigated the complex formation of cupric and nickelous
ions with o£-pyridinyl carbinols. Whereas pyridyl-2-
carbinol was almost as strong a complexing agent as
oxine, introduction of a methyl group in the <*.'
position heavily decreased complex formation. Similar
reductions in stability have been noted in 2—substituted
8-hydroxyquinolinates, these also being ascribed to.
94steric hindrance
This argument can be used to explain the
relative decrease of an<^  ^2
alkylsalicylic acids. It was earlier stated that
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evidence from infra-red and dissociation constant 
measurements indicated that it was possible that 
3-alkyl groups caused reduction in the 0-H....0 
distance. While this resulted in greater 
stabilisation of the hydrogen bonded 3-alkylsalicylatbe 
ion, it is very probable that this reduction in the
0....0 distance would destabilise the complex: with 
the much bulkier ferric ion (ionic radius 0.6 2; cf. 
normal covalent radius of hydrogen ion: 0.3 2 
through, for example, distortion of valency angles.
On the evidence available, it is likely that the 
relative lowering of K-^  and Kg in 6-methyl-salicylic 
acid results from inhibition of mesomerism through 
distortion of the chelate ring, this distortion being 
caused by the interaction of the methyl- group with 
the bulky carboxyl, group. This conclusion would be 
in agreement with the view that the higher pKa of 
6-methylsalicylic acid relative to that of salicylic 
acid itself arises from distortion of the chelate ring
in the molecule.
In ^-resorcylic acid an alternative
explanation of the low values of ^  and K2 is possible, 
apart from the phenomenon of steric hindrance. The 
effect of the 6-hydroxyl group will be to lower 
the IT electron density on the oxygen atom b through
-108-
hydrogen "bonding of oxygen atom a with the phenolic 
group;
This will discourage charge transfer from the ligand 
to the cation, so destabilising it relative to the 
salicylate complex.
All the remarks so far have applied only 
to the 1:1 and 1:2 complexes. The accuracy of 
measurement of Kj was not sufficiently great to 
draw conclusions regarding the influence of substituents.
-109-
Ihe complexes of salicyluric acid with ferric ion.
Salicyluric acid forms a similar series 
of complexes with ferric ion to salicylic acid.
However, in view of its somewhat different structure 
it is here considered separately from the other, 
simpler, derivatives of salicylic acid.
The lsl complex of salicyluric acid 
with ferric ion, FeR, poses an interesting problem as 
regards its structure. Two ymbnKle structures are 
possible, depending on whether the ferric ion is 
bonded to the carbonyl and phenolic groups, or the amide 
nitrogen and phenolic groups,
,COO”
C h “F«
C O O ”
CH
NH
Fc
Xgren, in his study of salieylamide,
concluded that the bonding to the ferric ion was
most probably through the carbonyl and phenolic
groups in view of the similarity of the wavelengths
of ™«.TT-iT,mm absorption of the complexes of salieylamide
and salicylic acid with iron(IIl)88. If this
argument can he accepted, it can he concluded that
the metal ion is bonded as in the first structure
above, since the wavelength of maximum absorption
- 110-
of the 1:1 complex of salicylic acid is 525 y*. while 
that for the corresponding complex of salicyluric 
acid is 515 This is also the more likely structure
on electronic considerations, since the presence 
of the carbonyl group adjacent to the amido-nitrogen 
would result in a partial positive charge on the 
nitrogen atom, so discouraging bonding by donation 
of electrons from it to the iron atom.
Hhe most probable structure of the 
protonated complex would be the following:
/C O O H
It is of interest to note that the values 
of K0 and Ki1 indicate that the dissociation constant
cl X
of the carboxylic group in the 1:1 complex, i.e. the 
equilibrium constant of the reaction,
FeRH2+ 3?eR+ + hT
is abnormally high (Ka = Kp/Kp1 = 17 mM; cf. Ka for 
salicyluric acid, O.389 mM). This could indicate
-1 1 1 -
an interaction between the carboxyl group and the 
complexed ferric ion. The proximity of the 
positively charged, iron atom to the carboxyl group 
would be expected to stabilise the carboxylate 
ion. Models of the molecule indicate that the 
carboxylate group can be brought close enough to 
the ferric atom for there to be a strong electrostatic 
interaction at least.
An alternative explanation is that the 
resonance form
tends to stabilise the carboxylate group by analogy
with glycine, However, if this were the case, since
the amido-nitrogen bears only a partial positive
charge, the strengthening of the acidity of the
carboxyl group would be expected to be considerably
less than in glycine. In fact, the species EeRH+ +
is a stronger acid than glycine (Ka for FeBH = 7
K n for glycine = ca* 5 mM). 
al
Thus it would appear likely that the 
relative stabilisation of the carboxylate ion in the 
complex FeRH arises through electrostatic interaction 
of the negatively charged carboxylate group with the 
positively charged iron atom, and may even involve 
some degree of covalent bonding between the two.
Comparison of biological and physical data
Although the physical properties studied 
have heen explained qualitatively at least, no such 
outcome can "be claimed for the comparison of "biological 
with physical properties.
All the salicylic acid derivatives examined 
have "been quantitatively investigated with regard to 
their metabolic stimulant properties by Andrews^*^. 
She obtained values of the molar potency ratios of 
the different compounds relative to salicylic acid 
from the gradient of the dose-response curve. These 
are shown in Table l8.
There would appear to have been little 
quantitative comparative work done on the anti-diabetic 
and anti-rheumatic properties of the salicylates: 
hence the paucity of information in the Table.
For comparison, results are also included 
in Table 18 of the proportion of salicylic acid, 
3-methylsalieylic acid, and 3-iso-propyl salicylic 
acid bound to plasma protein at pH 7*4 with a total 
substituted salicylate concentration of 2 mM^ (the 
therapeutically effective level); also the shift in 
carbonyl frequency of the simple molecule on 
substituting different alkyl groups in the salicylic
-114-
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acid nucleus^. This is denoted "by by cm"1 and
vU
is equivalent to [^co( salicylic afcid) - ^(substituted 
salicylic acid)] .
On examining Table 18 it is seen that there
is little correlation between pK and K-, on the one8* 1
hand, and the metabolic stimulant property. Within 
the series of 5-alkylsalicylic acids, it should be 
noted, however, that with increasing bulk of the 
3-substituent, the acidity, degree of protein binding, 
metabolic stimulant activity, and carbonyl frequency 
shift all increase, whereas the value of decreases. 
Apparently the metabolic stimulant activity increases 
with increasing bulk of the substituent in the 
3-posit&on as does the degree of protein binding. The 
possibility of a correlation between biological activity 
and protein binding will be considered later. The 
values of pKa, andAyCQ are of course also affected 
by the size of the » as discussed earlier.
This investigation was originally started 
to determine whether there was any simple correlation 
between the complexing power of salicylates towards 
ferric ions and their biological effects. In the 
light of the above results, this correlation would 
appear to be lacking, at least as far as its metabolic
stimulant property is concerned.
However, this fact does not necessarily 
mean that salicylate does not possess its biological 
activity by virtue of its ability to complex metal 
ions. This work was carried out using only one metal 
ion, viz., the ferric ion. It is possible, though 
unlikely, that using a different metal ion the stabilities 
of the different complexes might be correlated with 
the metabolic stimulant action of the different acids. 
Also, in the event of the salicylate molecule being 
biologically active through forming a protein-metal 
ion-salicylate complex, the relative stabilities of 
the metal ion-sal icy late complexes may not be similar 
to those in which a protein molecule is also involved.
The evidence reported here is therefore negative, 
and certainly lends no support to the idea of the 
salicylic acid molecule acting on biological systems 
through the formation of a metal complex.
Conclusion
As stated earlier, there would appear 
to "be no simple relation "between the complexing 
ability of the substituted salicylates towards ferric 
ions and their metabolic stimulant property. One 
is then still left with the unsolved problem of the 
mode of action of salicylate. A compound possessing 
the wide range of pharmacological actions of salicylate 
might either act in a large number of different ways, 
or possess one main property from which all the other 
actions stemmed.
!Ehe paper of Christensen^ has already been 
mentioned. This indicated one mechanism by which 
a compound such as salicylic acid might produce a 
number of reactions through one main action. It 
would appear to be the first that suggested the 
biological significance of the binding of salicylate 
to protein. In this connection, it is of interest 
to note that the order of strength of binding to 
plasma protein is 5-tert-butylsalieylie acid 
3-iso-propylsalicylie acid > 3-methylsalieylic acid > 
salicylic acid^, which is the same order as the 
molar potency ratios with respect to metabolic 
stimulation*^*
-118-
Even if valid, this explanation may 
account for only part of the action of salicylate, 
and the complete explanation is probably much more 
complex, and not reducible to one relatively simple 
main action.
Although it has not been possible to 
correlate the biological properties of the compounds 
in this work with the physical properties studied, 
in the course of the investigation the author was 
struck by the structural similarity between
2.4-dinitrophenol and salicylic acid on the one hand, 
and y£-keto-acids important in lipid metabolism, on 
the other. Examination of the literature showed 
that there was some evidence for the interference
of 2t4-dinitrophenol in lipid metabolism.
One action which has been reported for
2.4-dinitrophenol, though not for salicylic acid,
97-99is its ability to inhibit fatty acid metabolisnr 
and also fatty acid biosynthesis100. Since
2.4-dinitrophenol interferes with carbohydrate 
metabolism through the uncoupling of oxidative 
phosphorylation, it was initially thought that its 
effect on lipid metabolism resulted from this 
property, which would reduce the concentration of
-119-
adenosine triphosphate (ATP) available. However, 
Judah101 reported that added ATP did not reverse the 
inhibition of octanoate oxidation by 2,4—dinitrophenol. 
Witter, Newcomb and Stotz10 ,^ studying preparations of 
liver particles, showed that the inhibition by
2,4-dinitrophenol of the oxidation of a model substrate, 
sorbic acid, was not overcome by maintenance of the 
level of ATP with the phosphocreatinine transphorylase 
of! rabbitmuscle, or by the simultaneous addition of 
c*-ketoglutarate, malate, heat stable factor, or 
Co-enzyme I, but was released by washing the enzyme 
free from inhibitor. These results they took to 
indicate that the action of 2,4-dinitrophenol on fatty 
acid metabolism did not arise indirectly through its 
interference with the Krebs, Cycle, and that the 
presence of the phenol did not cause the destruction 
of a factor or enzyme necessary for the oxidation 
of fatty acids. Since they found that 2,4-dinitrophenol 
inhibited the formation of acetoacetate from sorbate 
but not from, pyruvate, they concluded that the 
dinitrophenol might inhibit the oxidation of fatty 
acids at some stage prior to the formation of
acetoacetate.
A possible mechanism for this is as
follows. It is accepted that long chain fatty acids
-120-
are degraded by a process of ^-oxidation, the 
following scheme applying, where R is part of 
■the fatty acid, carbon chain.
r-ch2-gh2-ch2-cooh
r~chq-ch=ch9-cooh
I
r-ch2-choh-ch2-cooh
R-CHp-CO-CHo-COOH
I
R-CH2-C00H + CH^COOH
At physiological pH the intermediate, 
R.GH2*00«CH2#C00H, will be to a large extent ionisecL, 
and will consist of two forms in tautomeric 
equilibrium:
Q^°- V ° ^
HGs^O
Cn 2 c ^2
R R
k«to cnol
A significant part of the acid will be present in 
the enolic form, which will, of course, be stabilised 
by hydrogen bonding* Comparison of the structure 
of the enolic form of the acid with that of 
2,4-dinitrophenol and of the salicylate ion indicates
-1 2 1 -
that there are striking formal similarities in 
the structures of the three compounds!
It is possible that "the 2,4—dinitrophenol may inhibit 
the stage in fatty acid, metabolism involving hydrolysis 
of the keto-acid by a process of competitive inhibition. 
If the reactive species were the enolic foim shown 
above, it should be possible for the dinitrophenol 
molecule to be adsorbed on to the enzyme surface but 
not to be metabolized, since the energy required to 
hydrolyse a double bondi in a benzene nucleus is very 
much greater than that required for the hydrolysis 
of the double bond of the enolic acid.
It is noteworthy that Popjak and lietz^00 
obtained: evidence for the inhibition by 2,4-dinitrophenol 
of fatty acid biosynthesis (which is believed to occur 
by a mechanism essentially the reverse of (i -oxidation) 
but no work seems to have been carried out to determine 
whether in this case the action is direct or mediated 
through the disruption of carbohydrate metabolism.
- 1 2 2 -
It would be of considerable interest 
to find out whether salicylic acid does have a 
similar action to 2,4-dinitrophenol in fatty acid 
metabolism. If so, it would indicate that the 
influence of salicylate on lipid metabolism might 
be a fruitful field of study.
In conclusion, this work has not been 
successful in correlating biological effects of 
salicylates with their complexing power. It is 
perhaps of consolation to note that in few cases has 
any major correlation between the physical properties 
and biological actions of drugs been shown. Further 
work in elucidating the mechanism or mechanisms of 
action of salicylate at cellular level would, however, 
in all probability, lead to a greater understanding 
of the processes of metabolism in general, quite 
apart from any benefit it might have in indicating 
the types of derivative of salicylate which would 
be most suitable for clinical applications.
appendix
In the early stages of the work described 
in this thesis, it was thought possible that the 
biological activity of the salicylates might arise 
from their ability to form complexes with metal ions.
In an attempt to stabilise these 
complexes of salicylic acid, at higher pH's, e.g. 
physiological pH, it was thought of interest t® 
synthesise a number of amino-acid conjugates of 
salicylic acid, and to examine whether the extra 
chelating group(s) introduced into the molecule 
resulted; in stabilisation, or otherwise, of the 
complexes with ferric ion.
These conjugates had the general formula
OH
CO.NH.CH.COOH
where R.CH(NH2)°000H represents the structure of an 
amino-acid.
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Following the general method of Fischer , 
the conjugates salicyloyl-& -alanine (m.p.150-151 ) 
and salicyloyl-aspar-tic acid (m.p.173-174 ) were 
readily synthesised, and were shown to he chromatographicafly
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pure (benzene-propionic acid-water; 2:2:1) and 
to give satisfactory analyses. However, using the 
same methods, it was not found possible to isolate 
crystalline samples of either salicyloyl-histidine 
or salicyloyl-asparagine, the final products being 
intractable gums, even though a number of 
purification techniques, including chromatography, 
were used.
The two compounds obtained pure, along 
with samples of salicyloyl-yS -alanine and salicyloyl- 
glutamic acid, supplied by Dr.C. J.W.Brooks, were all 
found to form violet complexes with ferric ions, 
similar to. salicylic acid. Examination of these 
complexes spectrophotometrically by Job*s method 
of Continuous Variations indicated that these four 
conjugates formed 1:1 metal ion : ligand complexes, 
in an analogous manner to salicylic acid.
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